Related Experiment Videos
Regression in basal cell carcinoma: an immunohistochemical analysis
M J Hunt1, G M Halliday, D Weedon
1Department of Dermatology, Royal Prince Alfred Hospital, Sydney, Australia.
The British Journal of Dermatology
|January 1, 1994
Summary
Immune cells, specifically CD4+ T cells, are key to the spontaneous regression of basal cell carcinomas (BCCs). Increased numbers of activated T cells in regressing BCCs suggest their crucial role in tumor clearance.
Area of Science:
- Immunology
- Dermatology
- Oncology
Background:
- Spontaneous tumor regression is linked to immune responses.
- Basal cell carcinoma (BCC) regression has been observed, but the underlying immune mechanisms are unclear.
Purpose of the Study:
- To investigate the role of immune cells in the regression of primary basal cell carcinomas.
- To identify specific immune cell phenotypes and activation states associated with tumor regression.
Main Methods:
- Immunocytochemistry was used to analyze immune cell infiltration in 45 primary BCCs (20 nodular, 25 superficial).
- Cellular phenotypes and activation markers (CD3+, CD4+, interleukin-2 receptor, MHC class II, CD1, macrophage antigen) were assessed in regressing versus non-regressing tumors.
Main Results:
- Regressing BCCs showed significantly higher infiltration of CD3+ and CD4+ T cells compared to non-regressing tumors.
- Increased expression of the interleukin-2 receptor, an early T cell activation marker, was observed in regressing BCCs.
- No significant differences were found in the expression of MHC class II, CD1, or macrophage antigens.
Conclusions:
- Activated CD4+ T cells play a significant role in the spontaneous regression of basal cell carcinomas.
- The findings highlight the importance of cellular immunity in BCC regression and suggest potential therapeutic targets.